JP2017537130A5 - - Google Patents

Download PDF

Info

Publication number
JP2017537130A5
JP2017537130A5 JP2017531184A JP2017531184A JP2017537130A5 JP 2017537130 A5 JP2017537130 A5 JP 2017537130A5 JP 2017531184 A JP2017531184 A JP 2017531184A JP 2017531184 A JP2017531184 A JP 2017531184A JP 2017537130 A5 JP2017537130 A5 JP 2017537130A5
Authority
JP
Japan
Prior art keywords
therapeutic agent
hydrogel
particles
functional group
xerogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017531184A
Other languages
English (en)
Japanese (ja)
Other versions
JP7092502B2 (ja
JP2017537130A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/064975 external-priority patent/WO2016094646A1/en
Publication of JP2017537130A publication Critical patent/JP2017537130A/ja
Publication of JP2017537130A5 publication Critical patent/JP2017537130A5/ja
Application granted granted Critical
Publication of JP7092502B2 publication Critical patent/JP7092502B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017531184A 2014-12-10 2015-12-10 ハイドロゲル薬物送達インプラント Active JP7092502B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462089994P 2014-12-10 2014-12-10
US62/089,994 2014-12-10
PCT/US2015/064975 WO2016094646A1 (en) 2014-12-10 2015-12-10 Hydrogel drug delivery implants

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020201207A Division JP2021046429A (ja) 2014-12-10 2020-12-03 ハイドロゲル薬物送達インプラント

Publications (3)

Publication Number Publication Date
JP2017537130A JP2017537130A (ja) 2017-12-14
JP2017537130A5 true JP2017537130A5 (enExample) 2019-01-24
JP7092502B2 JP7092502B2 (ja) 2022-06-28

Family

ID=55070156

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2017531184A Active JP7092502B2 (ja) 2014-12-10 2015-12-10 ハイドロゲル薬物送達インプラント
JP2020201207A Pending JP2021046429A (ja) 2014-12-10 2020-12-03 ハイドロゲル薬物送達インプラント

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020201207A Pending JP2021046429A (ja) 2014-12-10 2020-12-03 ハイドロゲル薬物送達インプラント

Country Status (8)

Country Link
US (1) US20160166504A1 (enExample)
EP (2) EP3858329A1 (enExample)
JP (2) JP7092502B2 (enExample)
KR (1) KR20170117384A (enExample)
CN (2) CN120501693A (enExample)
AU (1) AU2015360469B2 (enExample)
CA (1) CA2969716C (enExample)
WO (1) WO2016094646A1 (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014138085A1 (en) 2013-03-05 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular drug delivery
US20220118416A1 (en) * 2020-10-18 2022-04-21 Pathak Holdings Llc Crosslinked multilayered material compositions, methods for their preparation and applications thereof
EP3233058A1 (en) 2014-12-15 2017-10-25 The Johns Hopkins University Sunitinib formulations and methods for use thereof in treatment of glaucoma
CN107921237A (zh) 2015-04-27 2018-04-17 反射医学公司 交感神经心肺神经调节系统和方法
EP4279064A3 (en) * 2015-05-12 2024-02-28 Incept, LLC Drug delivery from hydrogels
US11458041B2 (en) 2015-10-08 2022-10-04 Ocular Therapeutix, Inc. Punctal plug and bioadhesives
CN108367079B (zh) 2015-11-12 2022-11-22 灰色视觉公司 用于治疗的聚集性微粒
WO2017091749A1 (en) 2015-11-25 2017-06-01 Incept, Llc Shape changing drug delivery devices and methods
WO2017139487A1 (en) 2016-02-09 2017-08-17 Northwind Medical, Inc. Methods, agents, and devices for local neuromodulation of autonomic nerves
WO2017165449A1 (en) * 2016-03-22 2017-09-28 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Thermoresponsive hydrogel containing polymer microparticles for noninvasive ocular biologic delivery
CN110035754A (zh) 2016-06-29 2019-07-19 图拉维治疗股份有限公司 通过自主神经系统的局部神经调节治疗败血症及相关炎性病况
EP3487586A4 (en) * 2016-07-20 2020-03-04 Emory University FORMULAS FOR THE SUPRACHOROIDAL SPACE OF AN EYE AND METHOD
JP7430529B2 (ja) * 2016-09-23 2024-02-13 インセプト・リミテッド・ライアビリティ・カンパニー 前房内薬物送達デポ
EP3621654A4 (en) 2017-05-10 2021-02-17 Graybug Vision, Inc. PROLONGED-RELEASE MICROPARTICLES AND SUSPENSIONS OF THESE INTENDED FOR MEDICAL THERAPY
WO2019043699A1 (en) * 2017-08-30 2019-03-07 Hadasit Medical Research Services And Development Ltd. DEVICES, KITS AND METHODS FOR REDUCING AND / OR PREVENTING INTRA-ABDOMINAL ADHESIONS
WO2019088292A1 (ja) * 2017-11-06 2019-05-09 コニカミノルタ株式会社 ハイドロゲル粒子およびその製造方法、ハイドロゲル粒子を内包する細胞または細胞構造体、ハイドロゲル粒子を用いた細胞活性の評価方法、並びにハイドロゲル粒子の徐放性製剤としての使用
BR112020017030A2 (pt) * 2018-02-20 2020-12-15 Advanced Aesthetic Technologies, Inc. Hidrogéis de alta concentração e métodos relacionados
AU2019299519B2 (en) 2018-07-02 2025-03-06 Incept Llc Methods and devices for in situ formed nerve cap
US20210315587A1 (en) 2018-07-02 2021-10-14 Tulavi Therapeutics, Inc. Methods and devices for in situ formed nerve cap with rapid release
CN112752568A (zh) * 2018-08-15 2021-05-04 微思有限公司 具有用于流动路径修饰的可生物降解材料的持续释出部件及相应的药物输送装置
CN110772376A (zh) * 2019-11-20 2020-02-11 韩熠 一种用于婴幼儿及儿童的医用眼贴及其制备方法
EP4074349A4 (en) * 2020-01-14 2024-02-07 Mochida Pharmaceutical Co., Ltd. COMBINATION AND METHOD FOR TREATING SUBJECTS WITH ALGIC ACID SALT
CA3166738A1 (en) 2020-02-06 2021-08-12 Charles D. Blizzard Travoprost compositions and methods for treating ocular diseases
CN115209926B (zh) * 2020-03-25 2024-05-14 学校法人福冈大学 用于眼内膜剥离术的制剂
FI3884929T3 (fi) * 2020-03-25 2023-08-07 Ocular Therapeutix Inc Tyrosiinikinaasi-inhibiittoria sisältävä silmäimplantti
CA3177005A1 (en) * 2020-04-27 2021-11-04 Michael Goldstein Methods of treating allergic conjunctivitis
CA3177759A1 (en) * 2020-05-15 2021-11-18 Je Min CHAE Methods and compositions for reducing intraocular pressure
EP4216929A1 (en) 2020-09-24 2023-08-02 Ocular Therapeutix, Inc. Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent
EP4344745A3 (en) 2020-09-24 2024-10-09 Ocular Therapeutix, Inc. Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
US12343454B2 (en) 2020-11-12 2025-07-01 Pramand LLC Hydrogels formed in situ and composition design for intrauterine use
CN116888198A (zh) * 2021-02-05 2023-10-13 花王株式会社 水凝胶结构体
CN113230019A (zh) * 2021-04-16 2021-08-10 南京佑羲医药科技有限公司 一种用于眼球玻璃体内植入的长效缓释给药装置
JP2025506375A (ja) * 2022-02-01 2025-03-11 オキュラ セラピューティクス,インコーポレイテッド 生物製剤のための制御放出インプラントとそれに対応する治療法
US12251466B2 (en) 2022-04-20 2025-03-18 Pramand LLC Single solution hydrogels with covalent bonding formed in situ, composition design and medical procedures using the hydrogels
CN115671036A (zh) * 2022-11-15 2023-02-03 上海交通大学医学院附属第九人民医院 用于治疗眼底和眼内疾病的凝胶药物
CN120897764A (zh) 2023-04-11 2025-11-04 视尔普斯眼科公司 包含阿西替尼多晶型物iv的眼部植入物
CN116687840B (zh) * 2023-08-03 2023-10-20 四川省医学科学院·四川省人民医院 一种用于治疗眼部病状的凝胶制剂及其制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3640741A (en) 1970-02-24 1972-02-08 Hollister Inc Composition containing gel
US3865108A (en) 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US4002173A (en) 1974-07-23 1977-01-11 International Paper Company Diester crosslinked polyglucan hydrogels and reticulated sponges thereof
DE2437629C3 (de) 1974-08-05 1978-09-21 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von unlöslichen in Wasser nur wenig quellbaren Polymerisaten von N-Vinyllactamen
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US4207893A (en) 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
US5160745A (en) 1986-05-16 1992-11-03 The University Of Kentucky Research Foundation Biodegradable microspheres as a carrier for macromolecules
US4741872A (en) 1986-05-16 1988-05-03 The University Of Kentucky Research Foundation Preparation of biodegradable microspheres useful as carriers for macromolecules
IL82834A (en) 1987-06-09 1990-11-05 Yissum Res Dev Co Biodegradable polymeric materials based on polyether glycols,processes for the preparation thereof and surgical artiicles made therefrom
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5162430A (en) 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5304595A (en) 1988-11-21 1994-04-19 Collagen Corporation Collagen-polymer conjugates
IL90193A (en) 1989-05-04 1993-02-21 Biomedical Polymers Int Polurethane-based polymeric materials and biomedical articles and pharmaceutical compositions utilizing the same
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
ATE203885T1 (de) * 1994-09-08 2001-08-15 Stryker Technologies Corp Bandscheibenkern aus hydrogel
US6371975B2 (en) 1998-11-06 2002-04-16 Neomend, Inc. Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers
WO1999021512A1 (en) 1997-10-27 1999-05-06 The Regents Of The University Of California Methods and pharmaceutical compositions for the closure of retinal breaks
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
CA2438193A1 (en) 2001-02-26 2002-09-06 Duke University Novel dendritic polymers and their biomedical uses
US6913765B2 (en) * 2001-03-21 2005-07-05 Scimed Life Systems, Inc. Controlling resorption of bioresorbable medical implant material
US20040131582A1 (en) 2002-02-26 2004-07-08 Grinstaff Mark W. Novel dendritic polymers and their biomedical uses
JP5628467B2 (ja) * 2003-06-26 2014-11-19 シヴィダ・ユーエス・インコーポレイテッドPsivida Us, Inc. 生体分解性徐放性ドラッグデリバリーシステム
US7129210B2 (en) 2003-07-23 2006-10-31 Covalent Medical, Inc. Tissue adhesive sealant
WO2006031358A2 (en) 2004-08-13 2006-03-23 Hyperbranch Medical Technology, Inc. Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
WO2006031388A2 (en) 2004-08-20 2006-03-23 Hyperbranch Medical Technology, Inc. Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
JP2008520783A (ja) * 2004-11-16 2008-06-19 ユニベルシテ・ド・リエージュ ヒドロゲルマトリックスおよびマイクロキャリアを含む活性物質供給システム
WO2007001926A2 (en) 2005-06-24 2007-01-04 Hyperbranch Medical Technology, Inc. Low-swelling hydrogel sealants for wound repair
WO2007005249A2 (en) 2005-06-29 2007-01-11 Hyperbranch Medical Technology, Inc. Nanoparticles and dendritic-polymer-based hydrogels comprising them
US9125807B2 (en) * 2007-07-09 2015-09-08 Incept Llc Adhesive hydrogels for ophthalmic drug delivery
EP3960215B1 (en) 2009-12-15 2024-10-16 Incept, LLC Implants and biodegradable fiducial markers
US8961501B2 (en) 2010-09-17 2015-02-24 Incept, Llc Method for applying flowable hydrogels to a cornea
US10226417B2 (en) * 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
EP3613413A1 (en) * 2011-12-05 2020-02-26 Incept, LLC Medical organogel processes and compositions
CA2865132A1 (en) * 2012-02-22 2013-08-29 Trustees Of Tufts College Compositions and methods for ocular delivery of a therapeutic agent
WO2014039012A1 (en) * 2012-09-06 2014-03-13 Nanyang Technological University Hyaluronic acid-based drug delivery systems

Similar Documents

Publication Publication Date Title
JP2017537130A5 (enExample)
Bhavsar et al. Functionalized and graft copolymers of chitosan and its pharmaceutical applications
Chatterjee et al. Stimuli-responsive hydrogels: An interdisciplinary overview
Chatterjee et al. Mucoadhesive polymers and their mode of action: A recent update
JP2012517330A5 (enExample)
TW201808310A (zh) 溶解特性優秀的透明質酸微結構體
Deshmukh et al. Pharmaceutical applications of various natural gums
JP2009542384A5 (enExample)
C Patel et al. Recent patents on stimuli responsive hydrogel drug delivery system
Jennings et al. Chitosan coatings to control release and target tissues for therapeutic delivery
Lawrence et al. Ionically cross-linked polymer networks for the multiple-month release of small molecules
Gilmore et al. Matrices for combined delivery of proteins and synthetic molecules
Thakker et al. Inter-polymer complex microspheres of chitosan and cellulose acetate phthalate for oral delivery of 5-fluorouracil
McGuckin et al. Transdermal delivery of pramipexole using microneedle technology for the potential treatment of Parkinson’s disease
Vasiliu et al. Chitosan-based polyelectrolyte complex hydrogels for biomedical applications
Manna et al. Recent update on alginate based promising transdermal drug delivery systems
WO2014077656A1 (ko) 초기 약물 방출이 감소된 고분자 미립자를 포함하는 주사용 조성물 및 이의 제조방법
JP2017527611A (ja) 脊髄損傷を有する患者において炎症を阻害するための組成物、及びそれを使用する方法
CN108463256A (zh) 生物可降解的植入物
Baghaei et al. Novel thermosensitive hydrogel composites based on poly (d, l‐lactide‐co‐glycolide) nanoparticles embedded in poly (n‐isopropyl acrylamide) with sustained drug‐release behavior
Panonnummal et al. Application of chitosan and its derivatives in transdermal drug delivery
Li et al. Advancements in Injectable Hydrogels for Controlled Insulin Delivery: A Comprehensive Review of the Design, Properties and Therapeutic Applications for Diabetes and Its Complications
Nadeem et al. Thermosensitive hydrogels: from bench to market
TWI660740B (zh) 水膠組合物及包含其之藥物傳輸系統
TW201517920A (zh) 交聯明膠撐體及使用其之生理活性物質控制釋放用撐體